Cievert, developer of a cancer patient management system, has secured two NHS Foundation Trusts in Nottingham and Colchester as clients. The deal was made possible through Newcastle Science City’s support.

Cievert was created three years ago as a spin-out of Newcastle-upon-Tyne Hospitals NHS Foundation Trust, affiliated with Nottingham University. Its lead product is Cas-per, which consists of a web-based patient management system for patients undergoing radiotherapy or chemotherapy.

Cas-per manages the entire process from first contact with healthcare professionals to completion, and takes care of both registration and referral process for the treatment. It allows oncologists to refer their NHS patients to any cancer treatment centre in the country, reducing waiting times and allowing professionals to focus on treatments rather than administrative processes.

The company claims that to date about 30,000 patients have benefitted from its software, and saved the NHS £100,000 ($165,725).

Chris Kennelly, managing director at Cievert, said: “I am delighted to have secured contracts with two large NHS Foundation Trusts. It was always my aim to create a product which would be innovative and, ultimately, beneficial to the end user – the patient. With so much pressure on the NHS currently, I truly believe that this software can make a difference. It is a proven concept, having been piloted in the North East already. Now I aim to make sure that as many cancer patients as possible can benefit from the efficiencies that this software can bring to their treatment.”